Precision BioSciences, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureAug 24 →Insiders3 insiders bought $33,714 in 3 open-market buys. 4 insiders sold $466,167, all 11 sales on a 10b5-1 plan.→HoldersAberdeen 8.4%Bleichroeder 7.6%Octagon Capital 5.1%→Financing →PeersClosest companies: MGX, BEAM, EDIT→
From the filings
Figures
- Revenue
- $45.1Mlast 12 months
- Net income
- −$52.7Mlast 12 months
- Operating cash flow
- −$58.7Mlast 12 months
- Cash and equivalents
- $86.1Mat the last balance sheet
- Shares outstanding
- 26.4M shareson issue